Millipore Sigma Vibrant Logo
Attention: We have moved. EMD Millipore products are no longer available for purchase on emdmillipore.com.Learn More

05-23-1200 Neurotensin - CAS 39379-15-2 - Calbiochem

Potent hypothalamic peptide neurotransmitter.

Neurotensin - CAS 39379-15-2 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Pyr-LYENKPRRPYIL

Primary Target: Modulator of noradrenergic activity
View Products on Sigmaaldrich.com
05-23-1200
Purchase on Sigma-Aldrich

Overview

Replacement Information

Key Specifications Table

CAS #Empirical Formula
39379-15-2C₇₈H₁₂₁N₂₁O₂₀

Products

Catalog NumberPackaging Qty/Pack
05-23-1200-5MG Plastic ampoule 5 mg
Description
OverviewPotent hypothalamic peptide neurotransmitter. An endogenous anti-psychotic compound that lowers blood pressure, increases vascular permeability, and increases plasma levels of glucagon, glucose, growth hormone and prolactin in rats. A modulator of noradrenergic activity. Heterogeneously distributed in the mammalian central nervous system and has many neurotransmitter-like characteristics.
Catalogue Number05-23-1200
Brand Family Calbiochem®
SynonymsPyr-LYENKPRRPYIL
References
ReferencesKinkead, B., et al. 1999. Biol. Psychiatr. 46, 340.
Tyler, B.M., et al. 1998. Brain Res. 792, 246.
Tsuda, K., and Masuyuma, Y. 1993. Am. J. Hypertens. 6, 473.
Product Information
CAS number39379-15-2
ATP CompetitiveN
FormWhite to off-white lyophilized solid
Hill FormulaC₇₈H₁₂₁N₂₁O₂₀
Chemical formulaC₇₈H₁₂₁N₂₁O₂₀
Hygroscopic Hygroscopic
ReversibleN
Sold on the basis of peptide contentY
Quality LevelMQ100
Applications
Biological Information
Primary TargetModulator of noradrenergic activity
Purity≥97% by HPLC
Physicochemical Information
Cell permeableN
Peptide ContentY
Peptide SequencePyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSQQ4482000
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage -20°C
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalog Number GTIN
05-23-1200-5MG 04055977206364

Documentation

Neurotensin - CAS 39379-15-2 - Calbiochem SDS

Title

Safety Data Sheet (SDS) 

Neurotensin - CAS 39379-15-2 - Calbiochem Certificates of Analysis

TitleLot Number
05-23-1200

References

Reference overview
Kinkead, B., et al. 1999. Biol. Psychiatr. 46, 340.
Tyler, B.M., et al. 1998. Brain Res. 792, 246.
Tsuda, K., and Masuyuma, Y. 1993. Am. J. Hypertens. 6, 473.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision18-September-2008 RFH
SynonymsPyr-LYENKPRRPYIL
DescriptionPotent hypothalamic peptide neurotransmitter. Lowers blood pressure, increases vascular permeability and increases plasma levels of glucagon, glucose, growth hormone and prolactin in rats. A modulator of noradrenergic activity. Heterogeneously distributed in the mammalian central nervous system and has many neurotransmitter-like characteristics.
FormWhite to off-white lyophilized solid
CAS number39379-15-2
RTECSQQ4482000
Chemical formulaC₇₈H₁₂₁N₂₁O₂₀
Peptide SequencePyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH
Purity≥97% by HPLC
Solubility5% Acetic acid (1 mg/ml)
Storage -20°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Standard Handling
Merck USA index14, 6486
ReferencesKinkead, B., et al. 1999. Biol. Psychiatr. 46, 340.
Tyler, B.M., et al. 1998. Brain Res. 792, 246.
Tsuda, K., and Masuyuma, Y. 1993. Am. J. Hypertens. 6, 473.